India Exchange Filings

Alkem Laboratories Q2 FY27 Board Meeting and Earnings Highlights

Alkem Laboratories Ltd approves Q2 FY27 results, with consolidated revenue of ₹4,552 crore and net profit of ₹667 crore

  • Revenue rose 13.8% year on year; operating margin was approximately 19.5%, versus 20.7% a year earlier.
  • Net profit fell 14.4% year on year; results included a ₹35 crore exceptional recovery against a previously impaired investment.
  • Deloitte issued unmodified limited-review conclusions, noting reliance on other auditors and certain unreviewed subsidiary and associate information.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.